Study of a Yellow Fever Vaccine in Young Children
Treatments studied
Part of Infections clinical trials.
This trial tests a new yellow fever vaccine in young children. It will see if the vaccine is safe and produces a good immune response, including when given with the MMR vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 9 months and 5 years old (or 11-15 months old if getting the MMR vaccine at the same time).
- Your child should be generally healthy, without any serious long-term illnesses.
- Your child cannot have had a yellow fever vaccine before.
- Your child cannot have a weakened immune system or take medications that suppress immunity.
- Your child should not have received any other vaccine in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if giving measles-rubella and yellow fever vaccines together on the same day is safe and works well for babies. It is for healthy infants aged 9-12 months who have not had these vaccines before. The goal is to see if giving both at once is a good option for protecting babies.
This study looks at how your immune system “remembers” the yellow fever vaccine over time. It may help researchers understand long-term immune protection and how it varies between people.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
This trial studies how well the yellow fever vaccine “17D” stimulates the immune system (the body’s germ-fighting response) in adults who were vaccinated with 17D years ago. It may help researchers understand whether a prior vaccination still provides protection and how strong the immune response is.
This study gathers safety and antibody information from women who received their first yellow fever vaccine either during pregnancy or outside of pregnancy. It aims to better understand how the vaccine affects pregnant women and their babies.
This trial checks whether a yellow fever vaccine is safe and works well in adults with HIV who have relatively healthy immune function. It may help doctors understand the best way to protect people with HIV who have never had this vaccine.
Hear when a new Yellow Fever Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.